哈尔滨誉衡药业股份有限公司关于 董事、高级管理人员通过司法拍卖 方式增持公司股份的自愿性披露公告

Core Viewpoint - Harbin Yuheng Pharmaceutical Co., Ltd. announced that its board member and general manager, Guo Leifeng, along with his concerted actor, Tibet Yupin Enterprise Management Partnership, successfully acquired a total of 25 million shares through a judicial auction, representing 1.12% of the company's total share capital [1][2]. Group 1: Shareholding Details - Yu Heng International Investments Corporation holds 56,778,123 shares, and Oriental Keystone Investment Limited holds 42,900,000 shares, which were publicly auctioned on Taobao from November 20 to November 21, 2025 [1]. - Guo Leifeng, as the general partner and executive partner of Tibet Yupin, is considered a concerted actor in this acquisition [2]. Group 2: Impact and Regulations - The judicial auction will not affect the company's normal production and operation activities, nor will it lead to a non-compliance in the company's shareholding distribution for listing requirements [2]. - Following the completion of the transfer, Guo Leifeng and Tibet Yupin are prohibited from reducing their shareholdings within six months [2].